Facebook Linkedin RSS Twitter Youtube
Home 2024

AIDS vaccine

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows
Infectious Diseases

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows

Momentary Open and Shut Change in HIV-1 Glycoprotein Structure Could Inform New Vaccine Design
Featured

Momentary Open and Shut Change in HIV-1 Glycoprotein Structure Could Inform New Vaccine Design

HIV Vaccine Clinical Trial Provides Promising Results
Drug Discovery

HIV Vaccine Clinical Trial Provides Promising Results

Study Suggests Patience is a Virtue When Vaccinating against HIV
Drug Discovery

Study Suggests Patience is a Virtue When Vaccinating against HIV

Developing Non-Affinity Purification for HIV and SARS-CoV-2 Vaccines
Bioprocessing

Developing Non-Affinity Purification for HIV and SARS-CoV-2 Vaccines

Newly Described Antibodies with “Special Shape” Could Unlock Vaccine Strategies for HIV, COVID
Coronavirus

Newly Described Antibodies with “Special Shape” Could Unlock Vaccine Strategies for HIV, COVID

AAV Vectors for Infectious Diseases
Insights

AAV Vectors for Infectious Diseases

Ten Predictions that Will Transform Healthcare
News

Ten Predictions that Will Transform Healthcare

HIV-AIDS Vaccines: Where Are We Now and Where Are We Heading?
News

HIV-AIDS Vaccines: Where Are We Now and Where Are We Heading?

HIV-AIDS Vaccine
Drug Discovery

HIV-AIDS Vaccine

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.